Acyclovir does work for cold sores, but its effect is modest. Both the cream and oral tablet forms can shorten a cold sore outbreak by roughly one day compared to no treatment. The biggest factor in how well it works isn’t the drug itself but how quickly you start using it. Acyclovir is most effective when applied or taken at the very first sign of a cold sore, during the tingling or itching stage before a blister forms.
How Acyclovir Stops Cold Sores
Acyclovir works by blocking an enzyme the herpes simplex virus needs to copy its DNA. Without that enzyme, the virus can’t replicate inside your cells. This is why timing matters so much: acyclovir can only interfere with the virus while it’s actively multiplying. Once the virus has already done its damage and your immune system’s inflammatory response has taken over, there’s less replication left to stop.
One important thing acyclovir cannot do is eliminate the virus from your body. Herpes simplex hides in nerve cells between outbreaks in a dormant state that no antiviral can reach. So acyclovir treats the outbreak, not the underlying infection, and it won’t prevent future cold sores on its own.
Cream vs. Tablets
Acyclovir comes in two main forms for cold sores: a 5% topical cream and oral tablets. Both reduce healing time by about one day, but they differ in convenience and how you use them.
The cream needs to be applied every two to three hours during the daytime for about four to five days. That’s a fairly demanding schedule, especially if you’re at work or school. The most common side effect is mild burning or stinging at the application site, but serious reactions are rare.
Oral tablets only need to be taken once or twice a day, depending on the dose, and treatment lasts one to seven days. In studies, the tablets caused no more side effects than a placebo. For people who find the cream’s frequent application schedule impractical, tablets are the easier option with the same approximate benefit. Oral acyclovir does require a prescription, while the cream is available over the counter in many countries.
Why Timing Makes All the Difference
Clinical trial data paints a clear picture: when patients started acyclovir early, before visible blisters appeared, they saw a 27% reduction in healing time and a 36% reduction in pain. But when patients in the same study started treatment after blisters had already formed, acyclovir did not significantly affect the duration of the outbreak, the size of the lesion, or whether the sore progressed further.
Cold sore lesions can mature within just eight hours of the first symptoms. That’s a narrow window. The practical takeaway is to keep your medication on hand rather than waiting to get it after symptoms start. The CDC recommends that people with frequent cold sores have a supply of medication ready so they can begin treatment the moment they feel tingling, itching, or notice redness. Waiting even a few hours can mean the difference between a shorter outbreak and no benefit at all.
How Acyclovir Compares to Valacyclovir
Valacyclovir is a newer drug that your body converts into acyclovir after you swallow it. The advantage is that it’s absorbed much more efficiently, so higher levels of the active drug reach your bloodstream. This allows for shorter, more intensive treatment courses. For cold sores specifically, valacyclovir is often prescribed as a single high dose taken twice in one day, compared to acyclovir’s multi-day regimen.
Both drugs target the same viral enzyme and produce similar results. The choice between them often comes down to convenience and cost. Acyclovir is available as a generic and tends to be cheaper, while valacyclovir offers simpler dosing.
Daily Use for Frequent Outbreaks
If you get cold sores several times a year, daily suppressive therapy is an option. Taking a low dose of acyclovir every day reduces the frequency and severity of outbreaks over time. This approach works best for people whose cold sores significantly affect their quality of life, whether from pain, appearance, or the disruption of repeated episodes. Treatment should be started early during any breakthrough outbreaks that do occur, as the same timing principle applies.
Resistance Is Rare
Some people worry that using acyclovir repeatedly will make the virus resistant. In practice, acyclovir-resistant herpes simplex is found in less than 1% of people with healthy immune systems, regardless of how many times they’ve been treated. Resistance is primarily a concern for people with significantly weakened immune systems, such as organ transplant recipients or those undergoing chemotherapy. For the vast majority of cold sore sufferers, acyclovir remains effective outbreak after outbreak.
Setting Realistic Expectations
Acyclovir is the most studied antiviral for herpes simplex, and it genuinely works. But “works” in this context means shaving roughly a day off an outbreak that might otherwise last seven to ten days, and reducing pain along the way. It won’t make a cold sore vanish overnight, and it won’t stop every outbreak from progressing to a blister. Its value is cumulative: used consistently and early, it makes cold sores shorter, less painful, and less disruptive over time. Skipping it or starting late, on the other hand, often produces results no different from doing nothing at all.